Legal & General Group Plc - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,163,842
-10.2%
151,028
-2.1%
0.00%
-50.0%
Q2 2023$4,636,815
-18.0%
154,252
-1.2%
0.00%0.0%
Q1 2023$5,656,590
-19.2%
156,130
-20.5%
0.00%
-33.3%
Q4 2022$7,003,128
+12.8%
196,331
+7.1%
0.00%
+50.0%
Q3 2022$6,207,000
+40.5%
183,367
+20.0%
0.00%0.0%
Q2 2022$4,418,000
-7.8%
152,767
+3.0%
0.00%
+100.0%
Q1 2022$4,794,000
-14.7%
148,312
-23.1%
0.00%
-50.0%
Q4 2021$5,622,000
+11.4%
192,787
+1.9%
0.00%0.0%
Q3 2021$5,046,000
+22.6%
189,202
+41.6%
0.00%
+100.0%
Q2 2021$4,115,000
-6.9%
133,651
-20.9%
0.00%
-50.0%
Q1 2021$4,421,000
+5.1%
168,885
+1.0%
0.00%0.0%
Q4 2020$4,207,000
+21.0%
167,215
+0.2%
0.00%0.0%
Q3 2020$3,478,000
-11.8%
166,902
+0.5%
0.00%0.0%
Q2 2020$3,944,000
+40.3%
166,044
+6.2%
0.00%0.0%
Q1 2020$2,812,000
-23.6%
156,315
+0.7%
0.00%0.0%
Q4 2019$3,680,000
-2.7%
155,155
+12.7%
0.00%0.0%
Q3 2019$3,782,000
-14.7%
137,620
+2.7%
0.00%0.0%
Q2 2019$4,433,000
-5.7%
133,961
-0.2%
0.00%
-33.3%
Q1 2019$4,702,000
+16.6%
134,189
+9.6%
0.00%0.0%
Q4 2018$4,033,000
-33.2%
122,407
+1.8%
0.00%
-25.0%
Q3 2018$6,039,000
-8.2%
120,214
+8.4%
0.00%
-20.0%
Q2 2018$6,582,000
+37.4%
110,896
+6.0%
0.01%
+25.0%
Q1 2018$4,791,000
+18.4%
104,580
+3.1%
0.00%
+33.3%
Q4 2017$4,046,000
+3.5%
101,460
+3.8%
0.00%0.0%
Q3 2017$3,910,000
+0.7%
97,778
+8.5%
0.00%0.0%
Q2 2017$3,881,000
+50.7%
90,087
+9.5%
0.00%
+50.0%
Q1 2017$2,575,000
+25.5%
82,272
+1.2%
0.00%0.0%
Q4 2016$2,052,000
+101.2%
81,278
+97.0%
0.00%
+100.0%
Q3 2016$1,020,000
+613.3%
41,249
+466.5%
0.00%
Q2 2016$143,000
+72.3%
7,282
+35.9%
0.00%
Q1 2016$83,000
+5.1%
5,358
-7.9%
0.00%
Q4 2015$79,0000.0%5,8180.0%0.00%
Q3 2015$79,000
-17.7%
5,8180.0%0.00%
Q2 2015$96,000
+43.3%
5,8180.0%0.00%
Q1 2015$67,000
+36.7%
5,8180.0%0.00%
Q4 2014$49,000
-3.9%
5,8180.0%0.00%
Q3 2014$51,0005,8180.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders